Норвегия -
норвежки -
Statens legemiddelverk
palexia 4 mg/ ml
grünenthal gmbh - tapentadolhydroklorid - mikstur, oppløsning - 4 mg/ ml
Европейски съюз -
норвежки -
EMA (European Medicines Agency)
roclanda
santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - Øyemidler - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.
Европейски съюз -
норвежки -
EMA (European Medicines Agency)
padcev
astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastiske midler - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.
Норвегия -
норвежки -
Statens legemiddelverk
tapentadol medical valley 250 mg
medical valley invest ab - tapentadoltartrat - depottablett - 250 mg
Норвегия -
норвежки -
Statens legemiddelverk
tapentadol medical valley 50 mg
medical valley invest ab - tapentadoltartrat - depottablett - 50 mg
Норвегия -
норвежки -
Statens legemiddelverk
tapentadol medical valley 100 mg
medical valley invest ab - tapentadoltartrat - depottablett - 100 mg
Норвегия -
норвежки -
Statens legemiddelverk
tapentadol medical valley 150 mg
medical valley invest ab - tapentadoltartrat - depottablett - 150 mg
Норвегия -
норвежки -
Statens legemiddelverk
tapentadol medical valley 200 mg
medical valley invest ab - tapentadoltartrat - depottablett - 200 mg
Норвегия -
норвежки -
Statens legemiddelverk
palexia depot 50 mg
orifarm as - tapentadolhydroklorid - depottablett - 50 mg